Jeffrey B Driban1, Grace H Lo2, Charles B Eaton2, Lori Lyn Price2, Bing Lu2, Timothy E McAlindon2. 1. From the Division of Rheumatology, and The Institute for Clinical Research and Health Policy Studies, Tufts Medical Center; Tufts Clinical and Translational Science Institute, Tufts University; Brigham and Women's Hospital; Harvard Medical School, Boston, Massachusetts; Medical Care Line and Research Care Line, Houston Health Services Research and Development (HSR&D) Center of Excellence, Michael E. DeBakey Veterans Affairs Medical Center; Section of Immunology, Allergy, and Rheumatology, Baylor College of Medicine, Houston, Texas; Center for Primary Care and Prevention, Alpert Medical School of Brown University, Providence, Rhode Island, USA.J.B. Driban, PhD, ATC, CSCS, Assistant Professor, Division of Rheumatology, Tufts Medical Center; G.H. Lo, MD, MSc, Assistant Professor, Medical Care Line and Research Care Line, HSR&D Center of Excellence, Michael E. DeBakey VA Medical Center, and Section of Immunology, Allergy, and Rheumatology, Baylor College of Medicine; C.B. Eaton, MD, MS, Director of Primary Care and Prevention, Center for Primary Care and Prevention, Alpert Medical School of Brown University; L.L. Price, MAS, Statistician, Instructor, The Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, and Tufts Clinical and Translational Science Institute, Tufts University; B. Lu, MD, DrPH, Assistant Professor, Brigham and Women's Hospital, and Harvard Medical School; T.E. McAlindon, MD, MPH, Chief of Division of Rheumatology, Division of Rheumatology, Tufts Medical Center. jeffrey.driban@tufts.edu. 2. From the Division of Rheumatology, and The Institute for Clinical Research and Health Policy Studies, Tufts Medical Center; Tufts Clinical and Translational Science Institute, Tufts University; Brigham and Women's Hospital; Harvard Medical School, Boston, Massachusetts; Medical Care Line and Research Care Line, Houston Health Services Research and Development (HSR&D) Center of Excellence, Michael E. DeBakey Veterans Affairs Medical Center; Section of Immunology, Allergy, and Rheumatology, Baylor College of Medicine, Houston, Texas; Center for Primary Care and Prevention, Alpert Medical School of Brown University, Providence, Rhode Island, USA.J.B. Driban, PhD, ATC, CSCS, Assistant Professor, Division of Rheumatology, Tufts Medical Center; G.H. Lo, MD, MSc, Assistant Professor, Medical Care Line and Research Care Line, HSR&D Center of Excellence, Michael E. DeBakey VA Medical Center, and Section of Immunology, Allergy, and Rheumatology, Baylor College of Medicine; C.B. Eaton, MD, MS, Director of Primary Care and Prevention, Center for Primary Care and Prevention, Alpert Medical School of Brown University; L.L. Price, MAS, Statistician, Instructor, The Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, and Tufts Clinical and Translational Science Institute, Tufts University; B. Lu, MD, DrPH, Assistant Professor, Brigham and Women's Hospital, and Harvard Medical School; T.E. McAlindon, MD, MPH, Chief of Division of Rheumatology, Division of Rheumatology, Tufts Medical Center.
Abstract
OBJECTIVE: We explored whether knee pain or a history of knee injury were associated with a knee injury in the following 12 months. METHODS: We conducted longitudinal knee-based analyses among knees in the Osteoarthritis Initiative. We included both knees of all participants who had at least 1 followup visit with complete data. Our first sets of exposures were knee pain (chronic knee symptoms and severity) at baseline, 12-month, 24-month, and 36-month visits. Another exposure was a history of injury that we defined as a self-reported injury at any time prior to baseline, 12-month, 24-month, or 36-month visit. The outcome was self-reported knee injury during the past year at 12-month, 24-month, 36-month, and 48-month visits. We evaluated the association between ipsilateral and contralateral knee pain or history of injury and a new knee injury within 12 months of the exposure using generalized linear mixed model for repeated binary outcomes. RESULTS: A knee with reported chronic knee symptoms or ipsilateral or contralateral history of an injury was more likely to experience a new knee injury in the following 12 months than a knee without chronic knee symptoms (OR 1.84, 95% CI 1.57-2.16) or prior injury (prior ipsilateral knee injury: OR 1.81, 95% CI 1.56-2.09. Prior contralateral knee injury: OR 1.43, 95% CI 1.23-1.66). CONCLUSION: Knee pain and a history of injury are associated with new knee injuries. It may be beneficial for individuals with knee pain or a history of injury to participate in injury prevention programs.
OBJECTIVE: We explored whether knee pain or a history of knee injury were associated with a knee injury in the following 12 months. METHODS: We conducted longitudinal knee-based analyses among knees in the Osteoarthritis Initiative. We included both knees of all participants who had at least 1 followup visit with complete data. Our first sets of exposures were knee pain (chronic knee symptoms and severity) at baseline, 12-month, 24-month, and 36-month visits. Another exposure was a history of injury that we defined as a self-reported injury at any time prior to baseline, 12-month, 24-month, or 36-month visit. The outcome was self-reported knee injury during the past year at 12-month, 24-month, 36-month, and 48-month visits. We evaluated the association between ipsilateral and contralateral knee pain or history of injury and a new knee injury within 12 months of the exposure using generalized linear mixed model for repeated binary outcomes. RESULTS: A knee with reported chronic knee symptoms or ipsilateral or contralateral history of an injury was more likely to experience a new knee injury in the following 12 months than a knee without chronic knee symptoms (OR 1.84, 95% CI 1.57-2.16) or prior injury (prior ipsilateral knee injury: OR 1.81, 95% CI 1.56-2.09. Prior contralateral knee injury: OR 1.43, 95% CI 1.23-1.66). CONCLUSION:Knee pain and a history of injury are associated with new knee injuries. It may be beneficial for individuals with knee pain or a history of injury to participate in injury prevention programs.
Authors: Benjamin M Goerger; Stephen W Marshall; Anthony I Beutler; J Troy Blackburn; John H Wilckens; Darin A Padua Journal: Br J Sports Med Date: 2014-02-21 Impact factor: 13.800
Authors: Amanda E Nelson; Kelli D Allen; Yvonne M Golightly; Adam P Goode; Joanne M Jordan Journal: Semin Arthritis Rheum Date: 2013-12-04 Impact factor: 5.532
Authors: Stephanie K Tanamas; Anita E Wluka; Miranda Davies-Tuck; Yuanyuan Wang; Boyd J Strauss; Joseph Proietto; John B Dixon; Graeme Jones; Andrew Forbes; Flavia M Cicuttini Journal: Arthritis Care Res (Hoboken) Date: 2013-01 Impact factor: 4.794
Authors: Jeffrey B Driban; Timothy E McAlindon; Mamta Amin; Lori L Price; Charles B Eaton; Julie E Davis; Bing Lu; Grace H Lo; Jeffrey Duryea; Mary F Barbe Journal: J Orthop Res Date: 2017-08-21 Impact factor: 3.494
Authors: Julie Davis; Charles B Eaton; Grace H Lo; Bing Lu; Lori Lyn Price; Timothy E McAlindon; Mary F Barbe; Jeffrey B Driban Journal: Clin Rheumatol Date: 2017-02-10 Impact factor: 2.980
Authors: Julie E Davis; Lori Lyn Price; Grace H Lo; Charles B Eaton; Timothy E McAlindon; Bing Lu; Mary F Barbe; Jeffrey B Driban Journal: Rheumatol Int Date: 2017-08-22 Impact factor: 2.631
Authors: Jeffrey B Driban; Lori Lyn Price; Charles B Eaton; Bing Lu; Grace H Lo; Kate L Lapane; Timothy E McAlindon Journal: Clin Rheumatol Date: 2015-11-27 Impact factor: 2.980
Authors: Felix C Hofmann; Jan Neumann; Ursula Heilmeier; Gabby B Joseph; Michael C Nevitt; Charles E McCulloch; Thomas M Link Journal: Skeletal Radiol Date: 2017-08-29 Impact factor: 2.199
Authors: Julie E Davis; Robert J Ward; James W MacKay; Bing Lu; Lori Lyn Price; Timothy E McAlindon; Charles B Eaton; Mary F Barbe; Grace H Lo; Matthew S Harkey; Jeffrey B Driban Journal: Rheumatology (Oxford) Date: 2019-03-01 Impact factor: 7.580
Authors: Jeffrey B Driban; Julie E Davis; Bing Lu; Lori Lyn Price; Robert J Ward; James W MacKay; Charles B Eaton; Grace H Lo; Mary F Barbe; Ming Zhang; Jincheng Pang; Alina C Stout; Matthew S Harkey; Timothy E McAlindon Journal: Arthritis Rheumatol Date: 2019-05-21 Impact factor: 10.995